louisiana semaglutide stomach paralysis lawyer Attorney Jonathan Orent joins NewsNation to discuss the wrongful death lawsuit filed against Novo Nordisk after Marsha Ettinghoff, a consumer of Ozempic, died from The GLP-1 RA Legal Timeline:

Pushing the Boundaries of GLP-1 Innovation Hanmi to Present Six Obesity Drug Studies at ADA 2025Hanmi Pharmaceutical to Unveil Six Research Updates on HM15275 and HM17321 at ADA 2025Phase 1 Results of Next-Generation Triple Agonist HM15275 to Be Unveiled for the First Time

Now theres a better way.The new Zepbound vial gives you the same powerful, prescription-strength ingredient ...

A new study shows that more Americans are choosing GLP-1 medications over bariatric surgery, but insurance coverage in Louisiana complicates that choice.

Semaglutide has an elimination half-life of approximately 1 week (7 days), which allows for once-weekly dosing and results in the drug being present in the c...

GLP-1 receptor agonists, such as semaglutide (you have probably heard of Ozempic), have gained attention for their impressive weight loss results

Discover why this combination lacks regulatory approval, the safety risks involved, and evidence-based alternatives recommended by UK clinical guidelines.